Olorofim

Absorption, Metabolism and Excretion of 14C-olorofim in Man

Drug-drug Interaction (DDI) Study to Assess Effect of Itraconazole and Rifampicin Upon Olorofim

A Biopharmaceutics Study to Assess the Pharmacokinetics of Single Oral and IV Doses of Olorofim

A Phase I Study to Assess the Pharmacokinetics of Olorofim in Subjects With Hepatic Impairment

A Phase I Study to Assess the Pharmacokinetics of Olorofim in Subjects With Renal Impairment

Evaluate F901318 (Olorofim) Treatment of Invasive Fungal Infections in Participants Lacking Treatment Options

Olorofim in Early Coccidioidal Meningitis

A Phase II Randomized Study to Evaluate Measures for Endpoint Derivation in Patients With Progressive or Refractory Disseminated Coccidioidomycosis Treated With Olorofim Plus Baseline Standard of Care or Placebo Plus Baseline Standard of Care

Olorofim Aspergillus Infection Study

A Phase III, adjudicator-blinded, randomised study to evaluate the efficacy and safety of treatment with olorofim versus treatment with AmBisome® followed by standard of care (SOC) in patients with invasive fungal disease (IFD) caused by Aspergillus species